Kinase inhibition in autoimmunity and inflammation

AA Zarrin, K Bao, P Lupardus, D Vucic - Nature Reviews Drug …, 2021 - nature.com
Despite recent advances in the treatment of autoimmune and inflammatory diseases, unmet
medical needs in some areas still exist. One of the main therapeutic approaches to alleviate …

Kinase inhibitors: the road ahead

FM Ferguson, NS Gray - Nature reviews Drug discovery, 2018 - nature.com
Receptor tyrosine kinase signalling pathways have been successfully targeted to inhibit
proliferation and angiogenesis for cancer therapy. However, kinase deregulation has been …

Structural features of the protein kinase domain and targeted binding by small-molecule inhibitors

C Arter, L Trask, S Ward, S Yeoh, R Bayliss - Journal of Biological …, 2022 - ASBMB
Protein kinases are key components in cellular signaling pathways as they carry out the
phosphorylation of proteins, primarily on Ser, Thr, and Tyr residues. The catalytic activity of …

Discovery of a selective inhibitor of doublecortin like kinase 1

FM Ferguson, B Nabet, S Raghavan, Y Liu… - Nature chemical …, 2020 - nature.com
Abstract Doublecortin like kinase 1 (DCLK1) is an understudied kinase that is upregulated in
a wide range of cancers, including pancreatic ductal adenocarcinoma (PDAC). However …

[PDF][PDF] Determination of effective albumin in patients with decompensated cirrhosis: clinical and prognostic implications

M Baldassarre, M Naldi, G Zaccherini, M Bartoletti… - …, 2021 - Wiley Online Library
Background and Aims Circulating albumin in cirrhosis can be dysfunctional because of
accumulating structural damages, leading to the concept of effective albumin concentration …

Impact of ERK5 on the Hallmarks of Cancer

B Stecca, E Rovida - International journal of molecular sciences, 2019 - mdpi.com
Extracellular signal-regulated kinase 5 (ERK5) belongs to the mitogen-activated protein
kinase (MAPK) family that consists of highly conserved enzymes expressed in all eukaryotic …

[PDF][PDF] Myelocytomatosis‐protein arginine N‐Methyltransferase 5 Axis defines the tumorigenesis and immune response in hepatocellular carcinoma

Y Luo, Y Gao, W Liu, Y Yang, J Jiang, Y Wang… - …, 2021 - Wiley Online Library
Background and Aims HCC is a leading cause of cancer‐related deaths globally with poor
outcome and limited therapeutic options. Although the myelocytomatosis (MYC) oncogene is …

Oncogenic signaling of MEK5-ERK5

VT Hoang, TJ Yan, JE Cavanaugh, PT Flaherty… - Cancer letters, 2017 - Elsevier
Mitogen-activated protein kinases (MAPKs) regulate diverse cellular processes including
proliferation, cell survival, differentiation, and apoptosis. While conventional MAPK …

An ERK5-NRF2 axis mediates senescence-associated stemness and atherosclerosis

J Abe, M Imanishi, S Li, A Zhang, KA Ko… - Circulation …, 2023 - Am Heart Assoc
Background: ERK5 (extracellular signal-regulated kinase 5) is a dual kinase transcription
factor containing an N-terminal kinase domain and a C-terminal transcriptional activation …

[HTML][HTML] Development of small molecule extracellular signal-regulated kinases (ERKs) inhibitors for cancer therapy

X Pan, J Pei, A Wang, W Shuai, L Feng, F Bu… - … Pharmaceutica Sinica B, 2022 - Elsevier
The mitogen-activated protein kinase (MAPK)/extracellular signal-regulated kinase 1/2
(ERK1/2) signaling pathway is widely activated by a variety of extracellular stimuli, and its …